US-based biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Friday a dividend of USD2.38 per share for the fourth quarter of 2025.
This amount is unchanged from Amgen's previous quarterly dividend.
It will be paid on 12 December 2025 to shareholders of record as of 21 November 2025.
Abbott declares quarterly dividend of USD0.63 per share
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
CVS Health announces quarterly dividend of USD0.665 per share
Convatec launches co-branded eakin freeseal ostomy seal in North America
UHS to acquire Talkspace for USD835m
Abbott announces quarterly dividend
Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit
Alvotech reports positive PK study results for AVT80 biosimilar candidate
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m
Citius Pharmaceuticals reports full-year financial results
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS